Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion
- 8 October 2020
- journal article
- research article
- Published by Elsevier BV in Canadian Journal of Ophthalmology
- Vol. 56 (2), 96-104
- https://doi.org/10.1016/j.jcjo.2020.09.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- CENTRAL RETINAL VEIN OCCLUSION IN YOUNG INDIVIDUALSRetina, 2019
- Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein OcclusionJAMA Ophthalmology, 2017
- Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusionAlbrecht von Graefes Archiv für Ophthalmologie, 2016
- Baseline Predictors of Visual Acuity and Retinal Thickness in Patients with Retinal Vein OcclusionJournal of Korean Medical Science, 2015
- Time to Clinically Significant Visual Acuity Gains after Ranibizumab Treatment for Retinal Vein OcclusionOphthalmology, 2014
- Baseline Characteristics and Risk Factors of Retinal Vein Occlusion: A Study by the Korean RVO Study GroupJournal of Korean Medical Science, 2013
- Visual Acuity Outcome and Predictive Factors after Bevacizumab for Central Retinal Vein OcclusionEuropean Journal of Ophthalmology, 2012
- Natural History of Visual Outcome in Central Retinal Vein OcclusionOphthalmology, 2011
- NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTSRetina, 2010
- The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and AustraliaOphthalmology, 2010